BioNova Scientific celebrated the grand opening of their newest facility at 2635 Technology Forest Blvd in The Woodlands. This expansion marks a major milestone not only for BioNova but also for the continued growth of The Woodlands as a rising hub for biotechnology and life sciences.
BioNova’s new plasmid DNA (pDNA) manufacturing facility represents a strategic investment in the future of advanced therapeutics. Plasmid DNA is an essential starting material in cell and gene therapy development, as well as mRNA-based vaccines. The new site will provide process development services as early as Q1 2025, with full GMP-grade production capabilities expected to come online later in the year. The facility is one of only a few in the United States capable of delivering end-to-end pDNA services at this scale and regulatory level.
The decision to locate at 2635 Technology Forest Blvd reinforces the appeal of The Woodlands for companies operating at the intersection of science, innovation, and advanced manufacturing. BioNova cited strong local support, workforce access, and supply-chain proximity as key factors in choosing to grow here. Notably, the project received tax abatements from Montgomery County and strategic backing from The Woodlands Township, illustrating the region’s commitment to fostering biotech growth.
Led by CEO Darren Head and a seasoned executive team, BioNova’s momentum in The Woodlands is far from over. The company has already announced plans for a second facility, projected at over 100,000 square feet, which will bring their total footprint in the area to nearly 200,000 square feet. This expansion is expected to create over 200 new jobs, adding to the region’s reputation as a magnet for life sciences talent and capital investment.
The significance of BioNova’s growth for commercial real estate in The Woodlands cannot be overstated. As part of Black Forest’s portfolio, 2635 Technology Forest Blvd stands as a key example of how premium, well-located assets can support highly specialized tenants in emerging sectors like biotech. With BioNova’s presence anchoring the site, the building and surrounding area are poised for increased long-term value—boosted by a rising tide of industry clustering from other firms such as Nurix Therapeutics and Cellipont Bioservices.
This investment further elevates Black Forest’s commitment to supporting innovation-driven tenants and nurturing industry ecosystems through real estate. As BioNova delivers critical materials to the global therapeutics market, Black Forest is proud to provide the infrastructure that enables their vision—and the science of tomorrow—to thrive here in The Woodlands.
For more information, visit bionovascientific.com
